Eupraxia Pharmaceuticals ...

NASDAQ: EPRX · Real-Time Price · USD
5.32
0.04 (0.76%)
At close: Aug 15, 2025, 3:49 PM
5.30
-0.43%
After-hours: Aug 15, 2025, 04:55 PM EDT

Eupraxia Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-25.74M -37.39M -23.92M -23.37M
Depreciation & Amortization
171.72K 209.91K 193.27K 111.53K
Stock-Based Compensation
3.22M 1.41M 1.43M 4.21M
Other Working Capital
-5.95M 6.47M 1.76M -402.32K
Other Non-Cash Items
-880.5K 1.53M 1.16M 3.41M
Deferred Income Tax
n/a n/a -305.15K 1.2M
Change in Working Capital
-6.76M 6.33M 2.07M -211.43K
Operating Cash Flow
-29.99M -27.92M -18.78M -14.64M
Capital Expenditures
-104.23K -73.38K -308.37K -431.67K
Cash Acquisitions
n/a n/a 310.00 n/a
Purchase of Investments
n/a n/a -310 -9M
Sales Maturities Of Investments
n/a n/a 9.01M n/a
Other Investing Acitivies
29.07K -1.81K 310.00 -5.02M
Investing Cash Flow
-75.16K -99.03K 8.7M -14.45M
Debt Repayment
-9.14M -144.44K -97.49K 12.17M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
363.06K 12.1M -87.7K -87.7K
Financial Cash Flow
45.78M 27.84M 13.52M 49.92M
Net Cash Flow
13.76M 1.08M 3.84M 20.74M
Free Cash Flow
-30.1M -28.02M -19.08M -15.07M